Kawasaki disease is an emerging health challenge in Nigeria. It is a rare short-term condition with prolonged fever and other manifestations, including skin rash, red eyes, and neck swelling.
In recent years, Kawasaki disease (KD) has become a significant worry for Nigerian pediatricians and health experts. This inflammatory illness, which primarily affects children under the age of five, presents substantial hurdles due to its cryptic nature and the possibility of severe repercussions if not properly recognized and treated.
What is Kawasaki disease?
Kawasaki disease, or mucocutaneous lymph node syndrome, is an acute illness that disrupts blood circulation into various body organs by continuously damaging and weakening all blood vessels, predominantly small and medium-sized blood arteries.
The damaged blood vessels can become weak and stretched, with a potential risk of tearing or narrowing. This limits the amount of blood that can be delivered to various tissues and organs, resulting in organ dysfunction.
Kawasaki disease affects all arteries, but the most concerning is the coronary arteries, which supply blood to the heart. Involvement of the heart poses a significant risk of heart failure and sudden death.
Epidemiology
Kawasaki disease was first reported in Japan in the 1960s and is primarily found in Asian people. However, its incidence has been observed worldwide, with different prevalence rates. The condition is under documented in Nigeria, making it difficult to understand its full impact.
Recent studies and clinical reports reveal that, while KD is uncommon in Nigeria, its prevalence may be underestimated due to a lack of awareness and diagnostic capacity. Many cases may be mistaken as other prevalent febrile infections, such as malaria or typhoid fever.
Symptoms
The symptoms of Kawasaki disease appear in stages and might be difficult to distinguish from those of other diseases that cause fever.
The first phase is heralded by a high fever lasting more than five days and not responding to common fever medication. Additional symptoms may include:
Rash: Typically extensive, affecting the trunk and limbs.
Conjunctivitis: Red eyes with no discharge.
Red, cracked lips and a swollen tongue (strawberry tongue).
Swollen hands and feet, usually with peeling skin.
Swollen lymph nodes in the neck.
Complications
Coronary artery aneurysms: caused by stretching blood vessels of the heart. In severe cases, blood vessels may burst, resulting in sudden death. This can be treated with medication or surgery in severe cases.
Valvular heart disease: Issues with the heart valves that help blood move in the right direction through your child’s heart.
Pancreatitis.
Heart failure.
Heart attack.
Multiple organ damage
Diagnosis
There is no specific diagnostic test for Kawasaki disease, but healthcare providers can perform tests to support a diagnosis or rule out other possible illnesses.
Diagnoses rely on symptoms and signs and require a high level of suspicion. Pediatricians employ standardized clinical criteria and may use echocardiography to identify suspected cases.
Management
Early treatment is critical to avoiding complications, notably heart coronary artery aneurysms, which can result in long-term heart problems.
The primary treatment consists of high-dose intravenous immunoglobulin (IVIG) and anti-inflammatory—the effectiveness of the treatment is reduced significantly if not provided within the first ten days of illness.
Fluids by IV for hydration.
Medications for pain and swelling.
Anticoagulants (blood thinners) for people at risk of blood clots.
Steroids or other anti-inflammatory medications to reduce inflammation in severe cases.
Cold compresses.
Access to IVIG can be difficult in Nigeria due to cost and availability. This emphasises the need for improved healthcare infrastructure and resource allocation to address such illnesses successfully.
Outlook
The prognosis is generally reasonable. Children can have Kawasaki disease symptoms for four to six weeks and may feel tired and irritable for up to eight weeks. After that, they gradually improve. Only about 2 to 3% of children may experience a recurrence.
Follow-up
People who have aneurysms and heart involvement from the disease need long-term follow-up for the rest of their lives.
Challenges and Recommendations
Many challenges impede the successful care of Kawasaki illness in Nigeria.
Lack of awareness exists among healthcare personnel and the general public, resulting in delayed diagnosis and treatment.
Diagnostic Difficulties: Similar presentation to more frequent febrile infections can lead to a misdiagnosis.
Resource constraints: Essential treatments such as IVIG are not widely available, and the hospital infrastructure could be improved.
To address these challenges, the following are recommended:
Enhanced Training: Pediatricians and general practitioners will receive regular training on recognizing and managing KD.
Public Awareness Campaigns: Raising awareness of KD through media and community health activities to educate parents about its indications and symptoms.
Improved Healthcare Infrastructure: Ensures the availability of critical pharmaceuticals and diagnostic tools throughout healthcare facilities.
Research and Surveillance: Conduct additional research to understand the epidemiology of KD in Nigeria better and establish a national registry to improve case monitoring and management.
Conclusion
Kawasaki illness, while uncommon, is a serious health concern in Nigeria that demands quick attention. By increasing awareness, diagnostic skills, and treatment infrastructure, Nigeria may better manage this condition and protect the health of its children. Collaboration among healthcare providers, policymakers, and the community is Required among healthcare practitioners, legislators, and community to reduce the burden of KD and ensure a healthier future for the nation’s kids.
MKO Abimbola holds a doctoral degree in physician associate studies from the United States of America. He is a Harvard Medical School scholar, who specializes in Internal medicine, Acute care, Emergency Medicine, Geriatrics, Psychiatry, and Surgical services.
Read the full article here
